BARACLUDE - BARACLUDE - CT 3487 - English version

icon

13

pages

icon

English

icon

Documents

2006

Lire un extrait
Lire un extrait

Obtenez un accès à la bibliothèque pour le consulter en ligne En savoir plus

Découvre YouScribe et accède à tout notre catalogue !

Je m'inscris

Découvre YouScribe et accède à tout notre catalogue !

Je m'inscris
icon

13

pages

icon

English

icon

Documents

2006

Lire un extrait
Lire un extrait

Obtenez un accès à la bibliothèque pour le consulter en ligne En savoir plus

Introduction BARACLUDE 0.5 mg film-coated tablet B / 30 (CIP : 376289-7) 30 aluminium blisters of 1 tablet BARACLUDE 1 mg film-coated tablet B / 30 (CIP : 376291-1) 30 aluminium blisters of 1 tablet BARACLUDE 0.05 mg/ml oral solution in a bottle B/1 (CIP : 376292-8) One 210 ml polyethylene bottle with a child-resistant closure and a polypropylene measuring spoon Posted on Aug 01 2008 Active substance (DCI) entecavir ATC Code J05AF10 Laboratory / Manufacturer BRISTOL-MYERS SQUIBB BARACLUDE 0.5 mg film-coated tablet B / 30 (CIP : 376289-7) 30 aluminium blisters of 1 tablet BARACLUDE 1 mg film-coated tablet B / 30 (CIP : 376291-1) 30 aluminium blisters of 1 tablet BARACLUDE 0.05 mg/ml oral solution in a bottle B/1 (CIP : 376292-8) One 210 ml polyethylene bottle with a child-resistant closure and a polypropylene measuring spoon Posted on Aug 01 2008
Voir icon arrow

Publié le

29 novembre 2006

Licence :

En savoir +

Paternité, pas d'utilisation commerciale, partage des conditions initiales à l'identique

Langue

English

 
 The legally binding text is the original French version   
TRANSPARENCY COMMITTEE  OPINION        29 November 2006   BARACLUDE 0.5 mg film-coated tablet B / 30 (CIP : 376289-7) 30 aluminium blisters of 1 tablet  BARACLUDE 1 mg film-coated tablet B / 30 (CIP : 376291-1) 30 aluminium blisters of 1 tablet  BARACLUDE 0.05 mg/ml oral solution in a bottle B/1 (CIP : 376292-8) One 210 ml polyethylene bottle with a child-resistant closure and a polypropylene measuring spoon  Applicant : BRISTOL-MYERS SQUIBB  entecavir List I  Medicinal product available only on an initial six-month medical prescription to be issued by specialists and/or departments specialised in gastroenterology, hepatology, internal medicine or infectious diseases Unrestricted renewal  Date of Marketing Authorisation: 26 June 2006  Reason for request: Inclusion on the list of medicines reimbursed by National Health Insurance and approved for use by hospitals                  Health Technology Assessment Division
 
1
Voir icon more
Alternate Text